ALPMF
Price
$10.70
Change
+$0.24 (+2.29%)
Updated
Aug 6 closing price
Capitalization
26.55B
JNJ
Price
$173.05
Change
+$1.52 (+0.89%)
Updated
Aug 8, 12:24 PM (EDT)
Capitalization
380.22B
74 days until earnings call
Interact to see
Advertisement

ALPMF vs JNJ

Header iconALPMF vs JNJ Comparison
Open Charts ALPMF vs JNJBanner chart's image
Astellas Pharma
Price$10.70
Change+$0.24 (+2.29%)
Volume$1.85K
Capitalization26.55B
Johnson & Johnson
Price$173.05
Change+$1.52 (+0.89%)
Volume$8.66K
Capitalization380.22B
ALPMF vs JNJ Comparison Chart in %
Loading...
ALPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALPMF vs. JNJ commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMF is a Buy and JNJ is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (ALPMF: $10.70 vs. JNJ: $171.53)
Brand notoriety: ALPMF: Not notable vs. JNJ: Notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMF: 14% vs. JNJ: 112%
Market capitalization -- ALPMF: $26.55B vs. JNJ: $380.22B
ALPMF [@Pharmaceuticals: Major] is valued at $26.55B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $380.22B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMF’s FA Score shows that 1 FA rating(s) are green whileJNJ’s FA Score has 4 green FA rating(s).

  • ALPMF’s FA Score: 1 green, 4 red.
  • JNJ’s FA Score: 4 green, 1 red.
According to our system of comparison, JNJ is a better buy in the long-term than ALPMF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMF’s TA Score shows that 4 TA indicator(s) are bullish while JNJ’s TA Score has 4 bullish TA indicator(s).

  • ALPMF’s TA Score: 4 bullish, 4 bearish.
  • JNJ’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, JNJ is a better buy in the short-term than ALPMF.

Price Growth

ALPMF (@Pharmaceuticals: Major) experienced а +2.29% price change this week, while JNJ (@Pharmaceuticals: Major) price change was +4.12% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.43%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was +13.43%.

Reported Earning Dates

JNJ is expected to report earnings on Oct 21, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.43% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than ALPMF($26.6B). ALPMF has higher P/E ratio than JNJ: ALPMF (39.22) vs JNJ (30.34). JNJ YTD gains are higher at: 20.582 vs. ALPMF (8.519). ALPMF has higher annual earnings (EBITDA): 247B vs. JNJ (23.3B). ALPMF has more cash in the bank: 397B vs. JNJ (22.9B). JNJ (29.3B) and ALPMF (30B) have identical debt. ALPMF has higher revenues than JNJ: ALPMF (1.52T) vs JNJ (85.2B).
ALPMFJNJALPMF / JNJ
Capitalization26.6B380B7%
EBITDA247B23.3B1,060%
Gain YTD8.51920.58241%
P/E Ratio39.2230.34129%
Revenue1.52T85.2B1,783%
Total Cash397B22.9B1,734%
Total Debt30B29.3B102%
FUNDAMENTALS RATINGS
ALPMF vs JNJ: Fundamental Ratings
ALPMF
JNJ
OUTLOOK RATING
1..100
3776
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
21
Undervalued
PROFIT vs RISK RATING
1..100
10029
SMR RATING
1..100
10032
PRICE GROWTH RATING
1..100
4824
P/E GROWTH RATING
1..100
9782
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMF's Valuation (9) in the null industry is in the same range as JNJ (21) in the Pharmaceuticals Major industry. This means that ALPMF’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (29) in the Pharmaceuticals Major industry is significantly better than the same rating for ALPMF (100) in the null industry. This means that JNJ’s stock grew significantly faster than ALPMF’s over the last 12 months.

JNJ's SMR Rating (32) in the Pharmaceuticals Major industry is significantly better than the same rating for ALPMF (100) in the null industry. This means that JNJ’s stock grew significantly faster than ALPMF’s over the last 12 months.

JNJ's Price Growth Rating (24) in the Pharmaceuticals Major industry is in the same range as ALPMF (48) in the null industry. This means that JNJ’s stock grew similarly to ALPMF’s over the last 12 months.

JNJ's P/E Growth Rating (82) in the Pharmaceuticals Major industry is in the same range as ALPMF (97) in the null industry. This means that JNJ’s stock grew similarly to ALPMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMFJNJ
RSI
ODDS (%)
Bearish Trend 1 day ago
44%
Bearish Trend 1 day ago
42%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
44%
Momentum
ODDS (%)
Bullish Trend 1 day ago
50%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
42%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
49%
Bullish Trend 1 day ago
40%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
48%
Bullish Trend 1 day ago
40%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
41%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
43%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
47%
Bearish Trend 1 day ago
52%
Aroon
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
ALPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CLSE24.370.33
+1.37%
Convergence Long/Short Equity ETF
DDWM40.610.28
+0.69%
WisdomTree Dynamic International Eq ETF
IDEV76.890.53
+0.69%
iShares Core MSCI Intl Dev Mkts ETF
SIXZ28.690.05
+0.18%
AllianzIM US Lrg Cp 6M Bfr10 May/Nov ETF
APRT39.77-0.05
-0.12%
AllianzIM US Large Cap Buffer10 Apr ETF

ALPMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMF has been loosely correlated with ALPMY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMF jumps, then ALPMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMF
1D Price
Change %
ALPMF100%
N/A
ALPMY - ALPMF
38%
Loosely correlated
+0.67%
JNJ - ALPMF
13%
Poorly correlated
+0.55%
GRFS - ALPMF
10%
Poorly correlated
+0.19%
AZNCF - ALPMF
8%
Poorly correlated
-0.97%
ABBV - ALPMF
5%
Poorly correlated
+1.30%
More